Francis Lévi

Hepatic artery chronomodulated infusion of irinotecan, 5-fluorouracil and oxaliplatin against liver metastases in heavily pretreated patients with colorectal cancer.

S. Giacchetti, D. Castaing, M. Bouchahda, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer.

F. Lévi, H. Bismuth, J. Misset, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial.

F. Lévi, L. Dogliotti, C. Focan, 1994, Journal of the National Cancer Institute.

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU).

E. Van Cutsem, C. Punt, P. Hérait, 1999, European journal of cancer.